"The voice for cancer physicians and their patients in Massachusetts."

  • Home
  • MSCO Annual Meeting - Musicophilia: An Evening of Musical Tales in Oncology

MSCO Annual Meeting - Musicophilia: An Evening of Musical Tales in Oncology

  • 10 Nov 2021
  • 6:30 PM - 8:00 PM
  • Virtual

Registration


Register

Join us virtually as we dive into the evolution of music therapy!

The presentation will break down music in the field of oncology and several musical interventions you can tailor and use to help your patients. In addition, learn to consider our own relationship with music and the ways those relationships can be advanced to support your role as caregivers.

Program Agenda
  • 6:30 p.m.     Welcome: Dr. Kala Seetharaman, MSCO Board President
  • 6:35 p.m.     Audesse Award Presented
  • 6:45 p.m.     Oncologist of the Year Award Presented
  • 7:00 p.m.     Annual Meeting Educational Program:  Musicophilia: An Evening of Musical Tales in Oncology.  Kathleen M. Howland, Ph.D., Professor of Music Therapy, Berklee School of Music
  • 7:45 p.m.     Q&A
  • 8:00 p.m.     Program Concludes
Description

Through story and fact, the value of music and music therapy in oncology will be presented. Client stories on the use of music for resilience, anxiety management, and pain management will be presented through live and recorded examples to stimulate interest and advance knowledge of the myriad of ways that music can enhance well-being through cancer treatment, palliative care, and hospice care.

Objectives

After participating in this activity, attendees should be able to:

1. Explain the biological rationale for music in oncology

2. Distinguish music therapy from music-based interventions in oncological settings

3. Identify patient profiles that would benefit from music therapy interventions, namely pain and anxiety

4. Consider their own relationship to music and the ways those relationships can be advanced to support their roles as caregivers

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society and the Massachusetts Society of Clinical Oncologists. The Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Massachusetts Medical Society designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Download Full Program Brochure

Corporate Sponsors

PLATINUM MEMBERS

  • Astellas                     
  • AstraZeneca
  • BeiGene
  • Bristol-Myers Squibb
  • Daiichi-Sanky
  • Eisai
  • Exact Sciences
  • Genentech
  • Janssen Oncology
  • Karyopharm Therapeutics
  • Merck
  • Oncopeptides
  • Pharmacyclics
  • Takeda Oncology
Gold Members
  • Abbvie
  • Exelixis
  • Lilly Oncology
  • Novartis
  • Sanofi Genzyme
  • Seagen

Massachusetts Society of Clinical Oncologists (c)


P.O. Box 549154, Waltham, MA, 02451
t: 781.434.7329 | f: 781.464.4896 |email: msco@mms.org
Powered by Wild Apricot Membership Software